Your browser doesn't support javascript.
Revisiting the guidelines for ending isolation for COVID-19 patients.
Jeong, Yong Dam; Ejima, Keisuke; Kim, Kwang Su; Iwanami, Shoya; Bento, Ana I; Fujita, Yasuhisa; Jung, Il Hyo; Aihara, Kazuyuki; Watashi, Koichi; Miyazaki, Taiga; Wakita, Takaji; Iwami, Shingo; Ajelli, Marco.
  • Jeong YD; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Ejima K; Department of Mathematics, Pusan National University, Busan, Republic of Korea.
  • Kim KS; Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, United States.
  • Iwanami S; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Bento AI; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Fujita Y; Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, United States.
  • Jung IH; interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Aihara K; Department of Mathematics, Pusan National University, Busan, Republic of Korea.
  • Watashi K; International Research Center for Neurointelligence, The University of Tokyo, Tokyo, Japan.
  • Miyazaki T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Wakita T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
  • Iwami S; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan.
  • Ajelli M; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Elife ; 102021 07 27.
Article in English | MEDLINE | ID: covidwho-1328262
ABSTRACT
Since the start of the COVID-19 pandemic, two mainstream guidelines for defining when to end the isolation of SARS-CoV-2-infected individuals have been in use the one-size-fits-all approach (i.e. patients are isolated for a fixed number of days) and the personalized approach (i.e. based on repeated testing of isolated patients). We use a mathematical framework to model within-host viral dynamics and test different criteria for ending isolation. By considering a fixed time of 10 days since symptom onset as the criterion for ending isolation, we estimated that the risk of releasing an individual who is still infectious is low (0-6.6%). However, this policy entails lengthy unnecessary isolations (4.8-8.3 days). In contrast, by using a personalized strategy, similar low risks can be reached with shorter prolonged isolations. The obtained findings provide a scientific rationale for policies on ending the isolation of SARS-CoV-2-infected individuals.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Isolation / Quarantine / Practice Guidelines as Topic / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: ELife.69340

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Isolation / Quarantine / Practice Guidelines as Topic / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: ELife.69340